Literature DB >> 27326027

Depression in patients with hypertrophic cardiomyopathy: is there any relation with the risk factors for sudden death?

Artemis Igoumenou1, Giorgos Alevizopoulos2, Aris Anastasakis3, Errika Stavrakaki4, Pavlos Toutouzas3, Christodoulos Stefanadis3.   

Abstract

OBJECTIVES: The aim of this study was to investigate whether depressive symptoms are related to the risk factors for sudden death in patients with hypertrophic cardiomyopathy (HCM).
DESIGN: 121 patients diagnosed as having HCM were assessed for depressive symptomatology using the Beck Depression Inventory and the Center for Epidemiological Studies Depression Scale (CES-D) and followed up for a period of 2 years. For the interview, the authors used the Structured Clinical Interview for DSM-III/DSM-III-R. A multidimensional longitudinal study was carried out with both somatic and psychological symptoms and signs taken into consideration. SPSS was used for the statistical analysis.
RESULTS: (1) Patients with HCM are more depressed than the general population. (2) There is no positive correlation between the occurrence of depressive symptoms and the risk factors for sudden death in patients with HCM. (3) Patients at high risk for sudden death are not more depressed than the others. (4) Time from diagnosis of the cardiac disease is not related to the presence and severity of depressive symptoms.
CONCLUSIONS: Patients with HCM are more depressed than the general population. The authors suggest that depressive symptoms and risk factors for sudden death in these patients are not related. It is important to screen for mood disorders in this patient population in order to provide an early diagnosis and treatment of the psychiatric disease.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; anxiety; cardiomyopathy hypertrophic; depression; psychology/psychiatry; risk factors; sudden death

Year:  2012        PMID: 27326027      PMCID: PMC4898617          DOI: 10.1136/heartasia-2012-010099

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  24 in total

Review 1.  The impact of depression on the course and outcome of coronary artery disease: review for cardiologists.

Authors:  K L Lavoie; R P Fleet
Journal:  Can J Cardiol       Date:  2000-05       Impact factor: 5.223

2.  Major depressive disorder predicts cardiac events in patients with coronary artery disease.

Authors:  R M Carney; M W Rich; K E Freedland; J Saini; A teVelde; C Simeone; K Clark
Journal:  Psychosom Med       Date:  1988 Nov-Dec       Impact factor: 4.312

3.  Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population.

Authors:  S B Patten; J V Williams; E J Love
Journal:  Can J Psychiatry       Date:  1996-09       Impact factor: 4.356

4.  The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.

Authors:  A H Glassman; S P Roose; J T Bigger
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

Review 5.  Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid?

Authors:  S P Roose; E Spatz
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

6.  Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy.

Authors:  A Steptoe; A Mohabir; N G Mahon; W J McKenna
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 7.  Treating depression in patients with cardiovascular disease.

Authors:  S J Seiner; G Mallya
Journal:  Harv Rev Psychiatry       Date:  1999 Jul-Aug       Impact factor: 3.732

8.  Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation.

Authors:  Eva R Serber; Samuel F Sears; Christopher D Nielsen; William H Spencer; Karen M Smith
Journal:  Am J Cardiol       Date:  2007-11-15       Impact factor: 2.778

9.  Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Roberto Gistri; Pasquale Petrone; Elena Pedemonte; Daniela Vargiu; Franco Cecchi
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

Review 10.  Cardiovascular safety in depressed patients: focus on venlafaxine.

Authors:  J P Feighner
Journal:  J Clin Psychiatry       Date:  1995-12       Impact factor: 4.384

View more
  4 in total

1.  Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.

Authors:  Amanda M Dossat; Marcos A Sanchez-Gonzalez; Andrew P Koutnik; Stefano Leitner; Edda L Ruiz; Brittany Griffin; Jens T Rosenberg; Samuel C Grant; Francis D Fincham; Jose R Pinto; Mohamed Kabbaj
Journal:  FASEB J       Date:  2017-02-24       Impact factor: 5.191

2.  Isobaric Tags for Relative and Absolute Quantitation Identification of Blood Proteins Relevant to Paroxetine Response in Patients With Major Depressive Disorder.

Authors:  Chin-Chuen Lin; Hung Su; Jentaie Shiea; Tiao-Lai Huang
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

3.  Electroconvulsive therapy in a patient with hypertrophic cardiomyopathy: A case report.

Authors:  Marco Kufner; Caroline Nothdurfter; Dagmar Steffling; Andrea Baessler; Lars S Maier; Yasmin Qamar
Journal:  Clin Case Rep       Date:  2022-09-05

4.  Drug repositioning for psychiatric and neurological disorders through a network medicine approach.

Authors:  Thomaz Lüscher Dias; Viviane Schuch; Patrícia Cristina Baleeiro Beltrão-Braga; Daniel Martins-de-Souza; Helena Paula Brentani; Glória Regina Franco; Helder Imoto Nakaya
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.